Featured Speakers
Lysosomal Disease Summit 2026 will feature leading experts in lysosomal disease research, diagnostics, and clinical care. The programme brings together internationally recognized speakers to share emerging evidence, clinical insights, and advances shaping the field’s future.
Additional speakers will be announced as the programme develops.
Keynote Speakers
Professor Michael Gelb, PhD
University of Washington, Seattle, USA
A chemist by training, Professor Gelb has led pioneering work on assays that have expanded newborn screening for lysosomal diseases.
Keynote Topic:
Newborn Screening and Whole Genome Sequencing
Professor Jeff Szer, MD
Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Australia
Professor Szer is a clinical haematologist specializing in stem cell transplantation and non-malignant haematologic disorders. His work includes significant contributions to the understanding and treatment of Gaucher disease.
Keynote Title:
The Rapidly Evolving Treatment Landscape for Gaucher Disease Type 1
Programme Contributors
Additional speakers and session contributors will be confirmed in the coming months, representing a broad range of expertise across clinical practice, research, and health systems.